Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

39.07
Delayed Data
As of Jun 28
 +0.64 / +1.67%
Today’s Change
33.60
Today|||52-Week Range
50.40
+2.41%
Year-to-Date

Today’s Trading

Previous close38.43
Today’s open38.80
Day’s range38.61 - 39.27
Volume3,467,250
Average volume (3 months)5,822,603
Market cap$20.6B
Dividend yield--
Data as of 4:00pm ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)-45.88%
Earnings growth (this year)+6.12%
Earnings growth (next 5 years)+7.03%
Revenue growth (last year)+17.44%
P/E ratio16.8
Price/Sales1.79
Price/Book1.85

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+3.00+3.35%
INCYIncyte Corp+4.02+3.08%
ALXNAlexion Pharmaceutic...+3.70+3.03%
PRGOPerrigo Company PLC+1.80+2.41%
Data as of 4:00pm ET, 06/28/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)$1.17
Annual revenue (last year)$11.1B
Annual profit (last year)$480.0M
Net profit margin4.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts